Cytosine demethylation of the proteinase-3/myeloblastin primary granule protease gene during phagocyte development

Leukemia

Volumn 13, Issue 9, 1999, Pages 1420-1427

  Lubbert, M ^a   Tobler, A ^b   Daskalakis, M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

DNA methylation; Gene expression; Myeloperoxidase; Neutrophils; Transcription

Indexed keywords

CD34 ANTIGEN; CYTOSINE; MESSENGER RNA; MYELOBLASTIN; MYELOPEROXIDASE; SCLEROPROTEIN; SERINE PROTEINASE;

ARTICLE; BONE MARROW CELL; BONE MARROW CULTURE; CELL CULTURE; CELL DIFFERENTIATION; CELL GRANULE; CELL MATURATION; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; GRANULOCYTE; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PHAGOCYTE; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN DEGRADATION; STEM CELL;

EID: 0032860485     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401486     Document Type: Article

References (54)

1. Klebanoff SJ. Myeloperoxidase-mediated cytotoxic systems. In: Sbarra AJ, Strauss RR (eds). The Reticuloendothelial System, vol 2. Plenum: New York, 1980, pp 279-308.
2. Borregaard N, Cowland UB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997; 89: 3503-3521.
3. Sagoh T, Yamada M. Transcriptional regulation of myeloperoxidase gene expression in myeloid leukemia HL-60 cells during differentiation into granulocytes and macrophages. Arch Biochem Biophys 1988; 262: 599-604.
4. Tobler A, Miller CW, Johnson KR, Selsted ME, Rovera G, Koeffler HP. Regulation of gene expression of myeloperoxidase during myeloid differentiation. J Cell Physiol 1988; 136: 215-225.
5. Yoshimura K, Crystal RG. Transcriptional and post-transcriptional modulation of human neutrophil elastase gene expression. Blood 1989; 79: 2733-2740.
6. Labbaye C, Zhang J, Casanova J-L, Lanotte M, Teng J, Miller WH, Cayre YE. Regulation of myeloblastin messenger RNA expression in myeloid leukemia cells treated with all-trans retinoic acid. Blood 1993; 81: 475-481.
7. Grisolano JL, Sclar GM, Ley TJ. Early myeloid cell-specific expression of the human cathepsin G gene in transgenic mice. Proc Natl Acad Sci USA 1994; 91: 8989-8993.
8. Rasmussen PB, Björn S, Hastrup S, Nielsen PF, Norris K, Thim L, Wiberg FC, Flodgaard H. Characterization of recombinant human HBP/CAP37/azurocidin, a pleiotropic mediator of inflammation-enhancing LPS-induced cytokine release from monocytes. FEBS Lett 1996; 390: 109-112.
9. Lübbert M, Miller CW, Koeffler HP. Changes of DNA methylation and chromatin structure in the human myeloperoxidase gene during myeloid differentiation. Blood 1991; 78: 345-356.
10. Bories D, Raynal MC, Solomon DH, Darzynkiewicz Z, Cayre YE. Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells. Cell 1989; 59: 959-968.
11. Chen T, Meier R, Ziemiecki A, Fey MF, Tobler A. Myeloblastin/proteinase 3 belongs to the set of negatively regulated primary response genes expressed during in vitro myeloid differentiation. Biochem Biophys Res Comm 1994; 200: 1130-1135.
12. Tenen DG, Hromas R, Licht JD, Zhang DE. Transcription factors, normal myeloid development, and leukemia. Blood 1997; 90: 489-519.
13. Jorgenson KF, Antoun GR, Zipf TF. Chromatin structural analysis of the 5′ end and contiguous flanking region of the myeloperoxidase gene. Blood 1991; 77: 159-164.
14. Lübbert M, Oster W, Ludwig WD, Ganser A, Mertelsmann R, Herrmann F. A switch toward demethylation is associated with the expression of myeloperoxidase in acute myeloblastic and promyelocytic leukemias. Blood 1992; 80: 2066-2073.
15. Hashinaka K, Yamada M. Undermethylation and DNase 1 hypersensitivity of myeloperoxidase gene in HL-60 cells before and after differentiation. Arch Biochem Biophys 1992; 293: 40-45.
16. Labbaye C, Musette P, Cayre YE. Wegener autoantigen and myeloblastin are encoded by a single mRNA. Proc Natl Acad Sci USA 1991; 88: 9253-9256.
17. Hoidal JR, Rao NV, Gray B. Myeloblastin: leukocyte proteinase 3. In: Barrett AJ (ed). Methods in Enzymology, Vol. 244. Proteolytic Enzymes: Serine and Cysteine Peptidases. Academic Press: New York, 1994, pp 61-67.
18. Sturrock AB, Franklin KF, Rao G, Marshall BC, Rebentisch MB, Lemons RS, Hoidal JR. Structure, chromosomal assignment, and expression of the gene for proteinase-3. J Biol Chem 1992; 267: 21193-21199.
19. Zimmer M, Medcalf RL, Fink TM, Mattmann C, Lichter P, Jenne DE. Three human elastase-like genes coordinately expressed in the myelomonocytic lineage are organized as a single genetic locus on 19pter. Proc Natl Acad Sci USA 1992; 89: 8215-8219.
20. Sturrock AB, Espinosa R, Hoidal JR, LeBeau MM. Localization of the gene encoding proteinase-3 (the Wegener's granulomatosis autoantigen) to human chromosome band 19p13.3). Cytogenet Cell Genet 1993; 64: 33-34.
21. Pilat D, Fink T, Obermaier-Skrobanek B, Zimmer M, Wekerle H, Lichter P, Jenne DE. The human Met-ase gene (GZMM): structure, sequence, and close physical linkage to the serine protease gene cluster on 19p13.3. Genomics 1994; 24: 445-450.
22. Kao RC, Wehner NG, Skubitz KM, Gray BH, Hoidal JR. Proteinase 3: a distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J Clin Invest 1988; 82: 1963-1973.
23. Niles JL, McCluskey RT, Ahmad MF, Arnaout MA. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 1989; 74: 1888-1893.
24. Musette P, Labbaye C, Dorner MH, Cayre YE. Wegener's autoantigen and leukemia. Blood 1990; 76: 138-139.
25. Muller-Bérat N, Minowada J, Tsuji-Takayama K, Drexler H, Lanotte M, Wieslander J, Wiik A. The phylogeny of proteinase-3/myeloblastin, the autoantigen in Wegener's granulomatosis, and myeloperoxidase as shown by immunohistochemical studies on human leukemic cell lines. Clin Immunol Immunopathol 1994; 70: 51-59.
26. Jenne DE, Tschopp J, Lüdemann J, Utecht B, Gross WL. Wegener's autoantigen decoded. Nature 1990; 346: 520.
27. Specks U, Homburger HA. Anti-neutrophil cytoplasmic antibodies. Mayo Clin Proc 1994; 69: 1197-1198.
28. Lübbert M, Brugger W, Mertelsmann R, Kanz L. Developmental regulation of myeloid gene expression and demethylation during ex vivo culture of peripheral blood progenitor cells. Blood 1996; 87: 447-455.
29. Cross M, Dexter TM. Growth factors in development, transformation and tumorigenesis. Cell 1991; 64: 271-280.
30. Bird A. The essentials of DNA methylation. Cell 1992; 70: 5-8.
31. Lichtenstein M, Keini G, Cedar H, Bergman Y. B cell-specific demethylation: a novel role for the intronic kappa chain enhancer sequence. Cell 1994; 76: 913-923.
32. MacLeod AR, Szyf M. Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis. J Biol Chem 1995; 270: 8037-8043.
33. Jost JP, Jost YC. Mechanism of active DNA demethylation during embryonic development and cellular differentiation in vertebrates. Gene 1995; 157: 265-266.
34. Challita P-M, Skelton D, El-Khoueiry A, Yu X-J, Weinberg K, Kohn DB. Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J Virol 1995; 69: 748-755.
35. Veelken H, Re D, Kulmburg P, Rosenthal FM, Mackensen A, Mertelsmann R, Lindemann A. Systematic evaluation of chimeric marker genes on dicistronic transcription units for regulated expression of transgenes in vitro and in vivo. Hum Gene Ther 1996; 7: 1827-1836.
36. Antequera F, Boyes J, Bird A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 1990; 62: 503-514.
37. Jones PA, Wolkowicz MJ, Rideout III WM, Gonzales FA, Marziasz CM, Coetzee GA, Tapscott JC. De novo methylation of the MyoD CpG island during the establishment of immortal cell lines. Proc Natl Acad Sci USA 1990; 87: 6117-6121.
38. Bender C, Pao MM, Jones PA. Inhibition of DNA methylation by 5-Aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res 1998; 58: 95-101.
39. Herman JG, Merlo A, Mao L, Lapidus RG, Issa J-P, Davidson NE, Sidransky D, Baylin SB. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1997; 55: 4525-4530.
40. Schmitz A, Short M, Ammerpohl O, Asbrand C, Nickel J, Renkawitz R. Cis-elements required for the demethylation of the mouse M-lysozyme downstream enhancer. J Biol Chem 1997; 272: 20850-20856.
41. Lübbert M, Henschler M, Kreutz R, Andreesen R, Mertelsmann R, Herrmann F. The human lysozyme undergoes stepwise demethylation during phagocyte maturation. Leukemia 1997; 11: 990-997.
42. Felgner J, Kreipe H, Heidorn K, Jaquet K, Heuß, Zschunke F, Radzun HJ, Parwaresch MR. Lineage-specific methylation of the c-fms gene in blood cells and macrophages. Leukemia 1992; 6: 420-425.
43. Kreutz M, Krause SW, Hennemann B, Rehm A, Andreesen R. Macrophage heterogeneity and differentiation: defined serum-free culture conditions induce different types of macrophages in vitro. Res Immunol 1992; 143: 107-115.
44. Lill MC, Lynch M, Fraser JK, Chung GY, Schiller C, Glaspy JA, Souza L, Baldwin GC, Gasson JC. Production of functional myeloid cells from CD34-selected hematopoietic progenitor cells using a clinically relevant ex vivo expansion system. Stem Cells 1994; 12: 626-637.
45. Abrink M, Gobi AE, Huang R, Nilsson K, Hellman L. Human cell lines U-937, THP-1 and Mono Mac 6 represent relatively immature cells of the monocyte-macrophage cell lineage. Leukemia 1994; 8: 1579-1584.
46. Lamerdin JE, McCready PM, Skowronski E et al. Sequence analysis of a 3.5 Mb contig in 19p13.3 between CDC34 and D19S342. (Unpublished.) NCBI accession number AC004799.
47. Ganz T, Lehrer RI. Antimicrobial peptides of leukocytes. Curr Opin Hematol 1997; 4: 53-58.
48. Sturrock A, Franklin KF, Hoidal JR. Human proteinase-3 expression is regulated by PU.1 in conjunction with a cytidine-rich element. J Biol Chem 1996; 271: 32392-32402.
49. Wijermans PW, Krulder JW, Huijgens PC, Neve P. Continuous infusion of low-dose 5-Aza-2′-deoxycytidine in elderly patients with high-risk myelodysplastic syndrome. Leukemia 1997; 11: 1-5.
50. Silverman LR, Holland JF, Weinberg RS, Alter BP, Davis RB, Ellison RR, Demakos EP, Cornell CJ Jr, Carey RW, Schiffer CA, Holland JF. Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes. Leukemia 1993; 7 (Suppl. 1): 21-29.
51. Silverman LR, Demakos EP, Peterson B, Odchimar-Reissig R, Nelson D, Kornblith AB, Stone R, Holland JC, Powell BL, DeCastro C, Ellerton J, Larson RA, Schiffer CA, Holland JF. A randomized controlled trial of subcutaneous azacitidine (Aza C) in patients with the myelodysplastic syndrome (MDS): a study of the Cancer And Leukemia Group B (CALGB). Proc Am Soc Clin Oncol 1998; 17: 14a (Abstr.).
52. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998; 393: 386-389.
53. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landberger N, Strouboulis J, Wolffe AP. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998; 19: 187-191.
54. Bhattacharya SK, Ramchandani KS, Cervoni N, Szyf M. A mammalian protein with specific demethylase activity for mCpG DNA. Nature 1999; 397: 579-583.